cobas HCV

FDA Premarket Approval P150015 S041

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

The sponsor has proposed changes to the products identified above as the outcome of periodic internal reviews of hazard information. Per the sponsor, hazard information is compared against the most current safety data sheet to confirm whether any updates are reflected in product labeling. The sponsor notes that updates to the product hazard information strengthen instructions to enhance the safe use of the device. Review of the redlined versions of labeling, included in the submission, confirms that there are no changes to product formulation or changes to how the user interacts with the product. The changes do not pose any safety or efficacy concerns and accordingly are acceptable.

Devicecobas HCV
Generic NameAssay, Hybridization And/or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,hepatitis C Virus
ApplicantRoche Molecular Systems, Inc.
Date Received2020-09-17
Decision Date2020-10-07
PMAP150015
SupplementS041
Product CodeMZP 
Advisory CommitteeMicrobiology
Supplement TypeSpecial (immediate Track)
Supplement ReasonLabeling Change - Indications/instructions/shelf Life/tradename
Expedited ReviewNo
Combination Product No
Applicant Address Roche Molecular Systems, Inc. 4300 Hacienda Drive pleasanton, CA 94588-2722

Supplemental Filings

Supplement NumberDateSupplement Type
P150015Original Filing
S041 2020-09-17 Special (immediate Track)
S040 2020-07-27 30-day Notice
S039
S038 2020-04-17 30-day Notice
S037 2020-01-10 30-day Notice
S036 2019-11-29 30-day Notice
S035 2019-09-20 30-day Notice
S034 2019-08-30 30-day Notice
S033 2019-08-06 30-day Notice
S032
S031 2019-05-09 30-day Notice
S030 2019-05-09 30-day Notice
S029 2019-04-24 30-day Notice
S028 2019-04-24 30-day Notice
S027 2019-04-10 30-day Notice
S026 2019-04-08 30-day Notice
S025 2019-04-03 30-day Notice
S024 2019-03-27 30-day Notice
S023 2018-12-14 30-day Notice
S022 2018-11-13 30-day Notice
S021 2018-11-09 30-day Notice
S020 2018-08-21 30-day Notice
S019
S018 2018-07-27 30-day Notice
S017 2018-06-29 30-day Notice
S016 2018-06-08 30-day Notice
S015 2018-06-04 30-day Notice
S014 2018-04-16 30-day Notice
S013 2018-03-01 30-day Notice
S012 2018-01-23 30-day Notice
S011 2017-11-22 30-day Notice
S010 2017-10-30 30-day Notice
S009 2017-09-27 30-day Notice
S008 2017-09-26 30-day Notice
S007 2017-07-14 30-day Notice
S006 2017-05-09 30-day Notice
S005 2016-11-22 Special (immediate Track)
S004 2016-08-08 Real-time Process
S003 2016-07-08 30-day Notice
S002 2016-04-07 30-day Notice
S001 2016-02-26 30-day Notice

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.